In this study, we hypothesized that emodin could reduce the production of pro-inflammatory cytokines, increase the levels of antioxidant factors, and ameliorate sepsis related intestinal mucosal barrier damage through the VDR/ Nrf2 /HO-1 signaling pathway. The gene discussed is NFE2L2; the disease is Sepsis.